Financial results - CRATAEGUS PHARMA SRL

Financial Summary - Crataegus Pharma Srl
Unique identification code: 18674838
Registration number: J37/297/2006
Nace: 4773
Sales - Ron
851.893
Net Profit - Ron
478
Employees
4
Open Account
Company Crataegus Pharma Srl with Fiscal Code 18674838 recorded a turnover of 2024 of 851.893, with a net profit of 478 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Crataegus Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 765.379 729.946 651.470 654.194 681.531 731.075 705.195 766.196 860.152 851.893
Total Income - EUR 765.595 729.950 651.474 654.198 681.534 731.867 717.205 806.318 869.262 855.107
Total Expenses - EUR 760.992 720.961 632.763 623.870 651.850 694.889 678.019 713.610 858.665 851.069
Gross Profit/Loss - EUR 4.603 8.989 18.711 30.328 29.683 36.978 39.186 92.709 10.597 4.038
Net Profit/Loss - EUR 2.800 6.810 14.498 23.726 23.062 31.331 33.059 86.258 4.531 478
Employees 7 7 7 6 6 5 5 4 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -0.4%, from 860.152 euro in the year 2023, to 851.893 euro in 2024. The Net Profit decreased by -4.028 euro, from 4.531 euro in 2023, to 478 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Crataegus Pharma Srl

Rating financiar

Financial Rating -
CRATAEGUS PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Crataegus Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Crataegus Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Crataegus Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Crataegus Pharma Srl - CUI 18674838

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 539.665 506.247 472.279 439.503 415.262 394.846 371.318 469.122 457.211 412.348
Current Assets 134.626 115.917 126.911 96.239 137.057 143.763 191.902 164.869 172.698 201.697
Inventories 66.001 62.421 62.284 47.648 54.856 51.403 48.518 100.368 56.240 75.058
Receivables 57.245 17.455 40.195 43.966 32.276 31.908 26.528 23.559 57.127 25.263
Cash 11.380 36.041 24.432 4.625 49.925 60.453 116.856 40.942 59.332 101.376
Shareholders Funds 411.626 414.238 421.726 370.022 353.213 365.898 390.842 433.296 390.594 388.889
Social Capital 34.916 34.560 33.975 33.351 0 32.085 31.374 31.471 31.376 31.200
Debts 264.582 208.548 177.501 165.720 166.401 172.712 172.378 200.695 239.315 225.156
Income in Advance 0 0 0 0 32.705 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 201.697 euro in 2024 which includes Inventories of 75.058 euro, Receivables of 25.263 euro and cash availability of 101.376 euro.
The company's Equity was valued at 388.889 euro, while total Liabilities amounted to 225.156 euro. Equity increased by 478 euro, from 390.594 euro in 2023, to 388.889 in 2024.

Risk Reports Prices

Reviews - Crataegus Pharma Srl

Comments - Crataegus Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.